Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVIV

InVivo Therapeutics (NVIV) Stock Price, News & Analysis

InVivo Therapeutics logo

About InVivo Therapeutics Stock (NASDAQ:NVIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$0.79
52-Week Range
N/A
Volume
1.89 million shs
Average Volume
8.25 million shs
Market Capitalization
$997 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InVivo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NVIV Stock News Headlines

InVivo Therapeutics Holdings Co (NVIVQ)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
InVivo Therapeutics Holdings Corp (NVIVQ)
InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corp.
See More Headlines

NVIV Stock Analysis - Frequently Asked Questions

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) issued its earnings results on Wednesday, May, 13th. The biotechnology company reported ($61.75) EPS for the quarter.

InVivo Therapeutics shares reverse split on Wednesday, April 27th 2022.The 1-25 reverse split was announced on Wednesday, April 27th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 27th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that InVivo Therapeutics investors own include Anavex Life Sciences (AVXL), Gilead Sciences (GILD), Tonix Pharmaceuticals (TNXP), Flexion Therapeutics (FLXN), OPKO Health (OPK), Acasti Pharma (ACST) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
5/13/2020
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVIV
CIK
1292519
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$6.48 per share
Price / Book
N/A

Miscellaneous

Free Float
3,029,000
Market Cap
$997 thousand
Optionable
Not Optionable
Beta
0.65

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:NVIV) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners